secwatch.observer — SEC 8-K summary
======================================

Issuer:     InMed Pharmaceuticals Inc. (INM)
CIK:        0001728328
Form:       8-K
Filed at:   2026-03-30T23:59:59+00:00
Accession:  0001062993-26-001697
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

InMed receives Nasdaq notice of bid price deficiency; 180 days to cure
----------------------------------------------------------------------

- Received Nasdaq notice on March 27, 2026; closing bid price below $1.00 for 30 consecutive days (Feb 11–Mar 26).
- Must achieve $1.00 or more for 10 consecutive business days within 180 calendar days to regain compliance.
- If not cured, may qualify for additional 180-day period, subject to other listing standards and possible reverse split.
- No immediate effect on listing; shares continue trading on Nasdaq under symbol INM.
- Company monitoring share price and exploring options, including reverse stock split if needed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1728328/000106299326001697/0001062993-26-001697-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1728328/000106299326001697/form8k.htm
  HTML page:      https://secwatch.observer/filing/0001062993-26-001697

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer